Infections in Patients with Cystic Fibrosis: Diagnostic Microbiology Update

Survival has improved in patients with cystic fibrosis (CF), in part because of aggressive antimicrobial management. Two multidrug-resistant environmental bacteria, the Burkholderia cepacia group and nontuberculous mycobacteria, have emerged. Improving genomic and proteomic technologies are allowing...

Descripción completa

Detalles Bibliográficos
Autor principal: Gilligan, Peter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115738/
https://www.ncbi.nlm.nih.gov/pubmed/24856524
http://dx.doi.org/10.1016/j.cll.2014.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115738/
https://www.ncbi.nlm.nih.gov/pubmed/24856524
http://dx.doi.org/10.1016/j.cll.2014.02.001

Ejemplares similares